MPDU1
Mannose-P-dolichol utilization defect 1 protein
Also known as: CDGIf, Lec35, MPU1_HUMAN, PQLC5, SL15, SLC66A5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75352
- Gene
- MPDU1
- Ensembl
- ENSG00000129255
- Chromosome
- 17
- Canonical length
- 247 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Mitochondria
OverviewNCBI Gene
This gene encodes an endoplasmic reticulum membrane protein that is required for utilization of the mannose donor mannose-P-dolichol in the synthesis of lipid-linked oligosaccharides and glycosylphosphatidylinositols. Mutations in this gene result in congenital disorder of glycosylation type If. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
247 residues, UniProt reviewed canonical sequence.
>O75352|MPDU1
1 MAAEADGPLK RLLVPILLPE KCYDQLFVQW DLLHVPCLKI LLSKGLGLGI VAGSLLVKLP
61 QVFKILGAKS AEGLSLQSVM LELVALTGTM VYSITNNFPF SSWGEALFLM LQTITICFLV
121 MHYRGQTVKG VAFLACYGLV LLVLLSPLTP LTVVTLLQAS NVPAVVVGRL LQAATNYHNG
181 HTGQLSAITV FLLFGGSLAR IFTSIQETGD PLMAGTFVVS SLCNGLIAAQ LLFYWNAKPP
241 HKQKKAQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MPDU1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 104 nTPM
Expression across tissuesHPA
Tissue
- liver: 104 nTPM
- choroid plexus: 84 nTPM
- kidney: 67 nTPM
- rectum: 65 nTPM
- colon: 61 nTPM
- bone marrow: 60 nTPM
Single-cell type
- syncytiotrophoblasts: 200 nCPM
- esophageal apical cells: 143 nCPM
- cytotrophoblasts: 142 nCPM
- migrating cytotrophoblasts: 121 nCPM
- extravillous trophoblasts: 119 nCPM
- hofbauer cells: 103 nCPM
Immune cell
- intermediate monocyte: 73 nTPM
- non-classical monocyte: 69 nTPM
- myeloid DC: 53 nTPM
- plasmacytoid DC: 49 nTPM
- classical monocyte: 44 nTPM
- T-reg: 26 nTPM
Brain region
- choroid plexus: 38 nTPM
- thalamus: 27 nTPM
- cerebellum: 25 nTPM
- white matter: 23 nTPM
- medulla oblongata: 22 nTPM
- spinal cord: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MPDU1.
Disease | AllUniProt
Conditions MPDU1 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1F (CDG1F) MIM:609180
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 137 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- MPDU1-congenital disorder of glycosylation
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dolichol-linked oligosaccharide biosynthetic process
- oligosaccharide biosynthetic process
- protein folding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MPDU1 as an antibody target. Whether an autoantibody or antibody against MPDU1 could matter depends on whether native MPDU1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MPDU1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MPDU1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...